HEATHER KRAMBULE: Open Payments
NPI 1568097715 · LAYTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$717 in 52 payments from 7 companies in 2025. Trend: 2023 $1,557 · 2024 $1,554 · 2025 $717
Food & beverage: $717
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $283 |
| Janssen Pharmaceuticals, Inc | 11 | $183 |
| Alkermes, Inc. | 9 | $136 |
| Lundbeck LLC | 2 | $38 |
| Neurocrine BioSciences, Inc. | 2 | $32 |
| Neuronetics, Inc. | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: VRAYLAR, LYBALVI, INVEGA SUSTENNA, REXULTI, INGREZZA, NEUROSTAR TMS THERAPY SYSTEM, ABILIFY ASIMTUFII, SPRAVATO.
Industry payments across UT — which companies pay providers there.
